ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON Public Limited Company

AGC Biologics is a global CDMO providing development and manufacturing services for protein-based biologics and advanced therapies.

AGC Biologics

AHRM is a specialty CRO that focuses on Health Economics and Outcomes Research. The company integrates and conducts clinical trials and outcomes research across various therapeutic areas.

Applied Healthcare Research Management Inc. (AHRM)

DISSH is a female-founded Australian fashion brand that offers a variety of clothing and accessories.

DISSH

ICON plc is a clinical research organisation (CRO) that provides services for drug development across various therapeutic areas and industry sectors, including consulting and commercial solutions.

Metric
Company Name	ICON Public Limited Company	AGC Biologics	Applied Healthcare Research Management Inc. (AHRM)	DISSH
Symbol	ICLR
MSH ID	COM:ICONPLC	COM:AGCBIO	COM:AHRMINC	COM:DISSH
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Consumer Goods
Industry	Medical - Diagnostics & Research	Biotechnology	Contract Research Organization (CRO)	Fashion
Country	IE	US	US	AU
Stage
Employee Count	41.15K
Website	iconplc.com	agcbio.com	ahrminc.com	dissh.com
LinkedIn			applied-healthcare-resource-management
Founders

Metric
Market Cap	27.17B
Enterprise Value
Monthly Web Traffic		17.06K	1	444.62K
Web Traffic Growth		0.56		0.14
Valuation
Raised Capital

Metric
Revenue	8.12B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.81B
EBITDA	1.69B
Operating Income	1.06B
Net Income	612.34M
EPS	7.46
Diluted EPS	7.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.28
Operating Profit Margin	0.13
EBITDA Margin	0.21
Net Profit Margin	0.09
Return on Equity	0.08
Return on Assets	0.04
Return on Capital Employed	0.08

COM:ICONPLC

ICON plc

Last Close

212.76

22/11 21:00

Market Cap

27.17B

Beta: -

Volume Today

2.25M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	42.50
P/B Ratio	2.44
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.42
EV Multiple	14.63

Metric
Days Sales Outstanding	134.60
Days Payables Outstanding	5.64
Days Inventory Outstanding	0.00
Operating Cycle	133.36
Cash Conversion Cycle	126.56
Asset Turnover	0.49

Metric
Operating Cash Flow	1.16B
Free Cash Flow	1.02B
Cash Flow to Debt	0.38
Operating Cash Flow/Sales	0.16
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	378.10M
Accounts Receivable	-78.58M
Inventory
Goodwill	9.02B
Debt to Capitalization	0.29
Debt to Assets	0.24
Current Ratio	1.19
Quick Ratio	1.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue
SG&A to Revenue